Select Page
Metabolic syndrome is extremely common in the US, affecting nearly 35% of the population, and has been increasing in prevalence over the past decade. There has been promising data recently published in leading journals regarding the utility of a polypill containing low doses of multiple medications meant to reduce cardiovascular risk. However, controversy remains whether this or a more tailored approach best improves patient outcomes. We are excited to welcome Dr. Aryan Aiyer and Dr. Philip Joseph to discuss this essential primary prevention topic.

Department of Medicine Grand Rounds
June 1, 2021

Annual Health Policy Debate: CVD Prevention

3:50 “Traditional Risk-Based Approach to the Prevention and Treatment of ASCVD: An Evolving Model That Works
Aryan Aiyer, MD
Assistant Professor of Medicine
Division of Cardiology
University of Pittsburgh School of Medicine

31:31 “A Polypill Approach to Primary CVD Prevention
Philip Joseph, MD
Associate Professor of Medicine
Division of Cardiology
Faculty of Health Sciences, McMaster University

View Presentation